Literature DB >> 8816798

Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system.

M Vidal1, P Braun, E Chen, J D Boeke, E Harlow.   

Abstract

Many biological processes rely upon protein-protein interactions. Hence, detailed analysis of these interactions is critical for their understanding. Due to the complexities involved, genetic approaches are often needed. In yeast and phage, genetic characterizations of protein complexes are possible. However, in multicellular organisms, such characterizations are limited by the lack of powerful selection systems. Herein we describe genetic selections that allow single amino acid changes that disrupt protein-protein interactions to be selected from large libraries of randomly generated mutant alleles. The strategy, based on a yeast reverse two-hybrid system, involves a first-step negative selection for mutations that affect interaction, followed by a second-step positive selection for a subset of these mutations that maintain expression of full-length protein (two-step selection). We have selected such mutations in the transcription factor E2F1 that affect its ability to heterodimerize with DP1. The mutations obtained identified a putative helix in the marked box, a region conserved among E2F family members, as an important determinant for interaction. This two-step selection procedure can be used to characterize any interaction domain that can be tested in the two-hybrid system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816798      PMCID: PMC38382          DOI: 10.1073/pnas.93.19.10321

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

Authors:  P A Hamel; R M Gill; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

2.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

Authors:  S W Hiebert; S P Chellappan; J M Horowitz; J R Nevins
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

3.  A rapid method for localized mutagenesis of yeast genes.

Authors:  D Muhlrad; R Hunter; R Parker
Journal:  Yeast       Date:  1992-02       Impact factor: 3.239

4.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

5.  Cell cycle-specific association of E2F with the p130 E1A-binding protein.

Authors:  D Cobrinik; P Whyte; D S Peeper; T Jacks; R A Weinberg
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun.

Authors:  P M Chevray; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter.

Authors:  A L Means; J E Slansky; S L McMahon; M W Knuth; P J Farnham
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Authors:  M Meyerson; E Harlow
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

9.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Cell cycle regulation of the human cdc2 gene.

Authors:  S Dalton
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  52 in total

1.  A genetic strategy to eliminate self-activator baits prior to high-throughput yeast two-hybrid screens.

Authors:  A J Walhout; M Vidal
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

Review 2.  The yeast two-hybrid system and its pharmaceutical significance.

Authors:  Z Topcu; K L Borden
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

3.  Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft.

Authors:  B K Kennedy; O W Liu; F A Dick; N Dyson; E Harlow; M Vidal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Functional interaction map of lyssavirus phosphoprotein: identification of the minimal transcription domains.

Authors:  Y Jacob; E Real; N Tordo
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  DNA-binding activity and subunit interaction of the mariner transposase.

Authors:  L Zhang; A Dawson; D J Finnegan
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

6.  Using the two-hybrid screen in the classroom laboratory.

Authors:  Daniel P Odom; Martha J Grossel
Journal:  Cell Biol Educ       Date:  2002

7.  Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins.

Authors:  T Yasugi; M Vidal; H Sakai; P M Howley; J D Benson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 8.  Analysing protein-protein interactions with the yeast two-hybrid system.

Authors:  Barry Causier; Brendan Davies
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

9.  High throughput flow cytometry based yeast two-hybrid array approach for large-scale analysis of protein-protein interactions.

Authors:  Jun Chen; Mark B Carter; Bruce S Edwards; Hong Cai; Larry A Sklar
Journal:  Cytometry A       Date:  2011-09-27       Impact factor: 4.355

Review 10.  Edgotype: a fundamental link between genotype and phenotype.

Authors:  Nidhi Sahni; Song Yi; Quan Zhong; Noor Jailkhani; Benoit Charloteaux; Michael E Cusick; Marc Vidal
Journal:  Curr Opin Genet Dev       Date:  2013-11-26       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.